“Monash University the world’s best (#1) for Pharmacy and Pharmacology in QS 
rankings”

https://www.monash.edu/news/articles/monash-university-the-worlds-best-1-for-pharmacy-and-pharmacology-in-qs-rankings

(Maybe tangential to link, but this is great for Australia. And can’t help 
feeling good, having three Degrees, and three Grad Dips, including a Master of 
Education (straight Distinctions & High Distinctions) via Monash Uni, wherein 
they apparently rate 13th in Education in the world? Apologies guys, however 
... go Monash! :)


Monash University has ranked number one globally in the 2022 QS World 
University Rankings by Subject for Pharmacy and Pharmacology for the first 
time, making it Australia’s top-performing university.

This is the first time an Australian university has taken the top position in 
this discipline, and Monash is the only Australian university to receive a 
number one position in this edition of the rankings, making it the highest 
performing Australian university in the subject rankings this year.

Consistently ranked in the top three for the last five years for Pharmacy and 
Pharmacology, including number two in 2021, the number one ranking is Monash’s 
best result in the annual global subject rankings.

The result leads to an impressive showing for Monash in this year’s rankings, 
with top tier rankings in Education (13th), Nursing (14th), Engineering - 
Mineral and Mining (22), Philosophy and Engineering - Civil and Structural 
(27), and Anatomy and Physiology (29th).

Monash University President and Vice-Chancellor Professor Margaret Gardner AC 
described the number one global ranking as a proud achievement for the 
University’s Faculty of Pharmacy and Pharmaceutical Sciences, and for the 
entire Monash community.

“Not only does this ranking place us as the number one university in Pharmacy 
and Pharmacology, it also demonstrates the excellence of our research and 
education in this field, which is critical for the future health of our 
community,” Professor Gardner said.

“It is a testament to the leadership of Faculty Dean, Professor Arthur 
Christopoulos, and the commitment and dedication of all Faculty staff. I offer 
my sincere thanks and congratulations to all who contributed to this remarkable 
result.”

The COVID19 pandemic and current mental health crisis have highlighted and 
reinforced the need for Australia to be at the forefront of modern drug 
discovery, development and manufacturing.

The Faculty, known for its high profile research through Monash Institute of 
Pharmaceutical Sciences (MIPS), is responsible for the development of 
Australia’s first mRNA vaccine candidate for COVID-19 and in 2021 launched the 
Neuromedicines Discovery Centre. The NDC is an end-to-end academic enterprise 
for the discovery, development, evaluation, manufacture, and clinical rollout 
of 21st-century medicines to treat mental health disorders, as well as the 
Medicines Manufacturing Innovation Centre, which supports Victorian biotech and 
pharma companies to develop a competitive edge and retain jobs within the state.

With the health sector under pressure, new ways to tackle existing health 
conditions are needed that go beyond the current medicines and practices. 
Monash is well-positioned physically, as part of the Monash Technology and 
Melbourne Biomedical Precincts, and through the breadth of its research 
capability, which extends from medicine discovery through to clinical 
application.

Faculty of Pharmacy and Pharmaceutical Sciences Dean, Professor Arthur 
Christopoulos, said: “The pandemic has certainly reinforced the crucial and 
frontline role that pharmacists and pharmaceutical scientists play in society. 
Over and above their normal services, we’ve seen the whole sector step up and 
play a huge role in vaccine rollout.

“In addition to developing Australia’s first mRNA COVID vaccine candidate, 
we’ve launched a number of major biotech startups,  including Septerna which 
launched in February 2022 with $140 million (AUD) worth of Series A financing 
from tier-one venture capital firm Third Rock Ventures in the US, and a new 
Centre to address the urgent need for safer and more effective medicines to 
treat mental ill-health,” Professor Christopoulos said.

“We've evolved our pharmacy and pharmaceutical sciences education programs to 
address the urgent global workforce demands in the rapidly expanding healthcare 
sector.

“It’s a dynamic vocation and we’re so proud that Monash has been recognised for 
its agility, resilience and global excellence in this field.”

Monash University also ranked in the top 20 list globally for faculties 
including key broad ranking highlights:

Subject & Rankings:

Social Sciences and Management  29th (up 17)

Engineering and Technology   =39th (up 19)

Life Sciences and Medicine  33rd (up 2)

Natural Sciences   55th (up 21)

Arts and Humanities  42nd (up 7)

Five Monash subjects also ranked number one in Australia: Pharmacy and 
Pharmacology, Chemistry, Materials Science, Statistics and Operational Research 
(equal first), Engineering – Chemical.

The QS World University Rankings assess the performance of more than 1,300 
universities worldwide. The Rankings are compiled from an analysis of more than 
13.9 million unique papers and global surveys by employers and academics.


For more information about the rankings visit http://www.topuniversities.com

Read more about what the Number 1 ranking means on Monash Lens  
https://lens.monash.edu/

_______________________________________________
Link mailing list
[email protected]
https://mailman.anu.edu.au/mailman/listinfo/link

Reply via email to